Outcomes of childhood pulmonary arterial hypertension in BMPR2 and ALK1 mutation carriers.

doi:10.1016/j.amjcard.2012.04.035

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Outcomes of childhood pulmonary arterial hypertension in BMPR2 and ALK1 mutation carriers.

The American journal of cardiology - 15 Aug 2012

Chida Ayako, Shintani Masaki, Yagi Hisato, Fujiwara Maya, Kojima Yasuko, Sato Hiroki, Imamura Shinichiro, Yokozawa Masato, Onodera Norio, Horigome Hitoshi, Kobayashi Tomio, Hatai Yoshiho, Nakayama Tomotaka, Fukushima Hiroyuki, Nishiyama Mitsunori, Doi Shouzaburo, Ono Yasuo, Yasukouchi Satoshi, Ichida Fukiko, Fujimoto Kazuto, Ohtsuki Shinichi, Teshima Hidetaka, Kawano Tatsuya, Nomura Yuichi, Gu Hong, Ishiwata Takahiro, Furutani Yoshiyuki, Inai Kei, Saji Tsutomu, Matsuoka Rumiko, Nonoyama Shigeaki, Nakanishi Toshio

Abstract excerpt

Mutations in the bone morphogenetic protein receptor type 2 (BMPR2) gene and the activin receptor-like kinase 1 (ALK1) gene have been reported in heritable pulmonary arterial hypertension (HPAH) and idiopathic pulmonary arterial hypertension (IPAH). However, the relation between clinical characteristics and each gene mutation in IPAH and HPAH is still unclear, especially in childhood. The aim of this study was to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Treatment Outcome

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Activin Receptors, Type II

Share to Bone Morphogenetic Protein Receptors, Type II

Share to Familial Primary Pulmonary Hypertension

Share to Hypertension, Pulmonary

Share to Prognosis

Share to Survival Rate

Share to Vasodilator Agents

Source

Open in PubMed

Identifiers

PMID: 22632830
DOI: 10.1016/j.amjcard.2012.04.035

Genes

BMPR2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Outcomes of childhood pulmonary arterial hypertension in BMPR2 and ALK1 mutation carriers.PMID 22632830Read ↗

Genes in pediatric pulmonary arterial hypertension and the most promising BMPR2 gene therapySemantic proximity Read ↗

Implications of mutations of activin receptor-like kinase 1 gene (ALK1) in addition to bone morphogenetic protein receptor II gene (BMPR2) in children with pulmonary arterial hypertension.Semantic proximity Read ↗

Genetics of pulmonary arterial hypertension.Semantic proximity Read ↗

Heritable Forms of Pulmonary Arterial HypertensionSemantic proximity Read ↗

Genes and pulmonary arterial hypertension.Semantic proximity Read ↗

Prevalence and clinical features of bone morphogenetic protein receptor type 2 mutation in Korean idiopathic pulmonary arterial hypertension patients: The PILGRIM explorative cohort.Semantic proximity Read ↗

Genetics and Other Omics in Pediatric Pulmonary Arterial Hypertension.Semantic proximity Read ↗

Genes that drive the pathobiology of pediatric pulmonary arterial hypertension.Semantic proximity Read ↗

The role of genetics in pulmonary arterial hypertension.Semantic proximity Read ↗

Clinical and molecular genetic features of hereditary pulmonary arterial hypertension.Semantic proximity Read ↗

The Genetic Epidemiology of Pediatric Pulmonary Arterial Hypertension.Semantic proximity Read ↗

Genotypes and Phenotypes of Chinese Pediatric Patients With Idiopathic and Heritable Pulmonary Arterial Hypertension-A Single-Center Study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.